These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8155273)

  • 1. Immunotherapy for respiratory allergic diseases: indications, efficacy and monitoring.
    Negrini AC
    Allerg Immunol (Paris); 1993 Dec; 25(10):431-5. PubMed ID: 8155273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyposensitization treatment of allergic diseases].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of specific immunotherapy to mosquito bites.
    Ariano R; Panzani RC
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific immunotherapy--past--present--future].
    Kägi MK
    Praxis (Bern 1994); 1998 Sep; 87(40):1330-4. PubMed ID: 9816927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study.
    Ariano R; Panzani RC; Augeri G
    J Investig Allergol Clin Immunol; 1998; 8(3):155-60. PubMed ID: 9684188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
    Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy in the context of a clinical practice improvement program in the allergological setting: results of a long-term observational study.
    Marogna M; Massolo A
    Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):133-40. PubMed ID: 12793117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
    Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of immunotherapy on eosinophil activation in pollen sensitive children.
    Pronk-Admiraal CJ; Schilte PP; Bartels PC
    Clin Lab; 2001; 47(5-6):231-8. PubMed ID: 11405601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
    Marogna M; Spadolini I; Massolo A
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy].
    Modrzyński M; Mazurek H; Zawisza E
    Przegl Lek; 2005; 62(12):1337-42. PubMed ID: 16786743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
    Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of lumiward immunoassay system for detection of specific IgE associated with allergic rhinitis.
    Yamada K; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Hayashi M; Kishimoto K; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():169-77. PubMed ID: 9879417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and therapy of allergic diseases of the mucous membrane of the upper respiratory tract].
    Zenner HP
    Arch Otorhinolaryngol Suppl; 1987; 2():1-7. PubMed ID: 3330419
    [No Abstract]   [Full Text] [Related]  

  • 20. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.